The DOI matches its Crossref record.
Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.
Abstract
Conditioned media from LPS-activated rat peritoneal macrophages enhanced the proliferation rates of cultured rat glomerular mesangial cells. This macrophage-derived activity extensively co-purified with interleukin 1 (IL 1) activity through sequential ammonium sulfate precipitation, S-200 gel chromatography, DEAE-cellulose anion exchange chromatography, and phenyl-Sepharose chromatography. In addition, the macrophage-derived factor was heat-labile (80 degrees C) and inactivated by phenylglyoxal, thus allowing tentative identification as IL 1. Macrophage supernatants and purified IL 1 enhanced the proliferative rates of mesangial cells only in the presence of serum; the use of platelet-poor plasma or serum depleted of platelet-derived growth factor was without effect. IL 1 acted to increase the percentage of cycling cells, without a change in the length of the individual cell cycle times. These findings provide a potential mechanism whereby activated macrophages, in combination with platelet factors, enhance mesangial cell proliferation. Such processes may contribute to the mesangial hypercellularity frequently found in immune-mediated glomerulonephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Thornalley, P. J. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02054-3 · Cited by 591
Libby, P., Warner, S. J., & Friedman, G. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113346 · Cited by 533
Boyarsky, G., Ganz, M. B., Sterzel, R. B., & Boron, W. F. (1988) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1988.255.6.c844 · Cited by 409
Self-citationFriedman, S. L., & Arthur, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114362 · Cited by 401
Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
Remuzzi, G., & Bertani, T. (1990) · Kidney International · doi:10.1038/ki.1990.217 · Cited by 397
An update on human interleukin-1: From molecular biology to clinical relevance
Dinarello, C. A. (1985) · Journal of Clinical Immunology · doi:10.1007/bf00918247 · Cited by 374
Iida, H., Seifert, R., Alpers, C. E., Gronwald, R. G., Phillips, P. E., Pritzl, P., Gordon, K., Gown, A. M., Ross, R., & Bowen-Pope, D. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6560 · Cited by 293
Ganz, M. B., Boyarsky, G., Sterzel, R. B., & Boron, W. F. (1989) · Nature · doi:10.1038/337648a0 · Cited by 270
Self-citationPossible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 267
Pathogenesis and Significance of Nonprimary Focal and Segmental Glomerulosclerosis
Rennke, H. G., & Klein, P. S. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80001-0 · Cited by 255
Reconstruction of renal glomerular tissue using collagen vitrigel scaffold
Wang, P.-C., & Takezawa, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.529 · Cited by 59
Hirano, T., & Kishimoto, T. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_14 · Cited by 57
Metadata
- Authors
- Lovett, D. H., Ryan, J. L., & Sterzel, R. B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-12-01
- Volume
- 131
- Issue
- 6
- Pages
- 2830-2836
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1654490530
- Cited by
- 217
- References
- 0
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.